Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Altamira Therapeutics (OTCQB: CYTOF) reports 2024 financial results, focuses on expanding RNA delivery technology.

Altamira Therapeutics (OTCQB: CYTOF) reports 2024 financial results, focuses on expanding RNA delivery technology.

Unusual Whales

Apr 30, 2025 at 07:22 AM

Bermuda-based Altamira Therapeutics Ltd. (OTCQB: CYTOF) announced its business update and disclosed its financial performance for the full year of 2024. Altamira focuses on developing and marketing RNA delivery technology for non-liver targets.

Source: Unusual Whales The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

ALTAMIRA THERAPEUTICS LTD

CYTOF.US

Open

--

High

--

Low

--

Prev Close

--

P/E^TTM

--

Market Cap

--

LongbridgeAI